Anti-aging biotech NewLimit raises $435M at $3B+ valuation

NewLimit co-founder Brian Armstrong (Photographer: Stefan Wermuth/Bloomberg via Getty Images) June 2, 2026 01:34 PM EDT FinancingStartups An­ti-ag­ing start­up NewLim­it rais­es $435M at $3B+ val­u­a­tion, eyes clin­ic in 2027 Andrew Dunn Senior Biopharma Correspondent The Bay Area start­up NewLim­it has closed one of biotech’s largest pri­vate fi­nanc­ings of 2026 and ex­pects to start hu­man test­ing next year for its … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER